Martin Cid Magazine — Culture, Entertainment & World News

The dominant paradigm of metabolic treatment has long operated within a narrow frame: reduce caloric intake, increase caloric expenditure, manage the consequences. That framework is now obsolete. The emergence of triple receptor agonists, foremost among them retatrutide, represents a departure from symptom management toward systemic biological intelligence, engaging simultaneously the receptors for glucagon-like peptide-1, glucose-dependent […]